glp-1 and seizures 🔸 Should RAs be continued preprocedurally? 🔸 Who should stop a GLP-1 RA preoperatively? 🔸 Which patients should have their procedures postponed? “Perioperative Management of Patients Taking GLP-1 Receptor Agonists” explores Repurposing glucagon-like peptide-1 receptor agonists

Melatonin synergizes with Sorafenib to suppress pancreatic Cancer via melatonin receptor and PDGFR-/STAT3 pathway

Semaglutide starting dose: 0.5 mg weekly for cautious titration or 1.0 mg if prior dulaglutide tolerance

The variable this review flags The gap that no telehealth review can ignore is genetic context

Switching to a different GLP-1 drug altogether makes a difference in some cases, too - be it Byetta vs Ozempic or Bydureon vs Ozempic

To qualify, besides having Medicare drug coverage, you must have a body mass index of 35 or higher, or a BMI of 27 or higher alongside another health condition, such as a past heart attack or stroke, prediabetes or another from a list on the CMS website

Similarly, BMI decreased from 31.9 kg/m 2 (95% CI: 29.9, 33.9) at baseline to 28.9 kg/m 2 (95% CI: 27.0, 30.9) at 6 months, 27.8 kg/m 2 (95% CI: 25.8, 29.8) at 12 months, and 27.1 kg/m 2 (95% CI: 25.2, 29.1) at 18 months